Aidence has received a € 714,000 grant from Kansen voor West (“Opportunities for West”), a Dutch programme part of the European Regional Development Fund. The funding will support the development of an AI solution for treatment response assessment in lung cancer. We will build this solution in partnership with Erasmus University Medical Center (Erasmus MC) and The Netherlands Cancer Institute (Het Nederlands Kanker Instituut, NKI).
Our lung nodule assistant, Veye Chest, is currently used in routine practice and lung cancer screening across Europe. Veye Chest detects, measures, classifies and tracks the growth of pulmonary nodules on chest CT scans.
With this grant, we will extend the Veye product suite with an AI application for detecting and measuring larger masses on chest CTs. The new tool will automatically find and track the growth of lung tumours and indicate possible lymph-node metastases. Its results will provide insight into the effect of lung cancer treatments.
The goal is to support treatment response assessment in oncology and aid the testing of new medicine in clinical trials. The expectation is that the AI system will reduce the average time of scan reporting and increase measurement accuracy.
The project, called Imaging, is a joint effort with Erasmus MC and the NKI. Both academic hospitals bring extensive knowledge and experience in lung cancer care. Thus, this collaboration allows us to deliver a practical tool for clinical practice while advancing research on the benefits of medical imaging AI.
Lung cancer continues to be the leading cause of cancer-related deaths in Europe, responsible for approximately 1 in 5 cancer deaths. The Netherlands has one of the highest shares of lung cancer mortality in the EU. Last year, 13,500 people in the Netherlands received their lung cancer diagnosis, 800 (6%) of which in the Amsterdam region (figures from by Kansen voor West).
Kansen voor West
Kansen voor West is a partnership of the four provinces and large cities in the Randstad area of the Netherlands. The programme is supported by the European Regional Development Fund. Its aim is to give the regional economy an innovative impulse by granting subsidies to the business community.
Erasmus University Medical Center (Erasmus MC)
Erasmus MC is an innovative and world-leading center of scientific research. Their commitment is to achieving a healthy population and pursuing excellence in healthcare through research and teaching.
The Netherlands Cancer Institute (Het Nederlands Kanker Instituut, NKI)
NKI, founded in 1913, is among the top 10 comprehensive cancer centers. They combine world-class fundamental, translational, and clinical research with dedicated patient care.